Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Genentech (NYSE:DNA) formerly known as (NYSE:GNE)

No earlier versions found for this Subject.

Return to Genentech (NYSE:DNA) formerly known as (NYSE:GNE)

Genentech (DNA), The Biotechnology Juggernaut [tPA, Herceptin, Protropin...] Formerly Known As Genentech (GNE).

[June 18, 1999] "...Genentech, Inc. today announced Roche has formally exercised its option to cause Genentech to redeem all of its outstanding special common shares not owned by Roche.' on 'Jun 18, 1999'...The German pharmaceuticals giant will exercise its options to acquire the rest of the biotech company's shares it doesn't already hold and then re-issue shares in the company so that it may continue to trade as a distinct entity..."

Hoover's Profile of pending (NYSE:DNA) IPO hoovers.com

esecurities.com, DaytradersNewswire.com (tm), SiliconNewswire.com (tm), MicrocapNewswire.com (tm), WallStreetRadio.com (tm), DayTradersCafe.com (tm).